Global mRNA Vaccines and Treatment Drugs Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global mRNA Vaccines and Treatment Drugs market size will reach 16,870 Million USD in 2025 and is projected to reach 156,998 Million USD by 2032, with a CAGR of 37.53% (2025-2032). Notably, the China mRNA Vaccines and Treatment Drugs market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

mRNA (messenger RNA) vaccines and treatment drugs are a groundbreaking category of medical interventions that utilize synthetic mRNA molecules to instruct cells to produce specific proteins or antigens, triggering an immune response in the body. In the context of vaccines, mRNA vaccines, like those developed for COVID-19, deliver genetic instructions that enable the recipient＇s cells to produce a harmless piece of the target pathogen, such as a spike protein from the virus. This stimulates the immune system to create an immune response and generate protective antibodies. mRNA treatment drugs, on the other hand, leverage the same technology to address various diseases and conditions. By customizing mRNA to produce specific proteins or target cellular processes, these treatments offer potential therapies for a wide range of illnesses, including genetic disorders, cancer, and infectious diseases. The adaptability and rapid development capabilities of mRNA-based vaccines and treatment drugs have made them a transformative force in medicine and an innovative approach to disease prevention and therapy.

The major global suppliers of mRNA Vaccines and Treatment Drugs include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of mRNA Vaccines and Treatment Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global mRNA Vaccines and Treatment Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the mRNA Vaccines and Treatment Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Vaccines and Treatment Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of mRNA Vaccines and Treatment Drugs Include:

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA Vaccines and Treatment Drugs Product Segment Include:

Vaccines

Therapeutics

mRNA Vaccines and Treatment Drugs Product Application Include:

Disease Prevention

Tumor Immunity

Protein Replacement Therapy

Regenerative Therapy

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global mRNA Vaccines and Treatment Drugs Industry PESTEL Analysis

Chapter 3: Global mRNA Vaccines and Treatment Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global mRNA Vaccines and Treatment Drugs Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global mRNA Vaccines and Treatment Drugs Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global mRNA Vaccines and Treatment Drugs Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, mRNA Vaccines and Treatment Drugs Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more